Skip to content

A study for effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people

A study for effects of 2-weeks consecutive suction of hydrogen to auto nervous system, central nervous system, immune system, inflammation and cognitive function in elderly people - A study for effects of 2-weeks consecutive suction of hydrogen in elderly people

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027390
Enrollment
20
Registered
2017-05-21
Start date
2017-05-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

First visit: Testing after air suction, and then testing after hydrogen suction. At home: 5 times hydrogen suction in a day for 2 weeks. Second visit: Testing after air suction, and then testing after

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Females aged 25 to 40 years old. 2)Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1)Subjects who have smoking habit. 2)Subjects who are cold-sensitive constitution. 3)Subjects who are receiving medical treatment of sleep, mental, immune. 4)Subjects who are currently receiving medication due to treatment of disease. 5)In the past month, subjects who have had custom of taking or applying medicine for the treatment of diseases. 6)Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 7)Subjects with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 8)Subjects who have symptom of dermatologic disease such as atopic dermatitis. 9)Subjects who have undergone surgery on investigation objective portion within the past 6 months. 10)Subjects who are participating the other clinical tests of medicines or foods. Subjects who participated other clinical tests of medicines or foods within a month prior to the current study. 11)Subjects who themselves and/or their family are working for a company that develops, manufactures or sells health/functional foods and cosmetics. 12)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 13)Males who donated over 400mL blood within the last three month to the current study. 14)Females who donated over 400mL blood within the last four month to the current study. 15)Males who will be collected over 1200mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16)Females who will be collected over 800mL blood, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 17)Heavy alcohol drinker. 18)Others those have been determined ineligible by investigator.

Design outcomes

Primary

MeasureTime frame
Evaluation of psychology, evaluation of function of auto nervous system and central nervous system.

Secondary

MeasureTime frame
Evaluation of immuno-ability, inflammation and cognitive function.

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026